Maria Sancha Santos

Maria Sancha Santos

Auto-generated profile, based on publicly available information

Maria Sancha Santos

University of Coimbra

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
Cristina CarvalhoCristina Carvalho
Cristina Carvalho
Renato Xavier Coelho dos SantosRenato Xavier Coelho dos Santos
Renato Xavier Coelho dos Santos
SCSusana Cardoso
Susana Cardoso
SCSónia C. Correia
Sónia C. Correia
POPaulo Oliveira
Paulo Oliveira
Paula I. MoreiraPaula I. Moreira
Paula I. Moreira
The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers. Despite extensive clinical utilization, the mechanisms of action of DOX remain under intense debate. A growing body of evidence supports the view that this drug can be a double-edge sword. Indeed, injury to nontargeted tissues often complicates cancer treatment by limiting therapeutic dosages of DOX and diminishing the quality of patients life during and after DOX treatment. The literature shows that the heart is a preferential target of DOX toxicity. However, this anticancer drug also affects other organs like the brain, kidney and liver. This review is mainly devoted to discuss the mechanisms underlying not only DOX beneficial effects but also its toxic outcomes. Additionally, clinical studies focusing the therapeutic efficacy and side effects of DOX treatment will be discussed. Finally, some potential strategies to attenuate DOX-induced toxicity will be debated.

1 October 2004 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
POPaulo Oliveira
Paulo Oliveira
JBJames A. Bjork
James A. Bjork
MSMaria S. Santos
Maria S. Santos
RLRichard L. Leino
Richard L. Leino
MFM.Kent Froberg
M.Kent Froberg
KWKendall B. Wallace
Kendall B. Wallace

25 September 2007 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
Paula I. MoreiraPaula I. Moreira
Paula I. Moreira
PHPeggy L.R. Harris
Peggy L.R. Harris
XZXiongwei Zhu
Xiongwei Zhu
MSMaria S. Santos
Maria S. Santos
COCatarina R. Oliveira
Catarina R. Oliveira
George PerryGeorge Perry
George Perry
In this study, we evaluated the effect of lipoic acid (LA) and N-acetyl cysteine (NAC) on oxidative [4-hydroxy-2-nonenal, Nε -(carboxymethyl)lysine and heme oxygenase-1] and apoptotic (caspase 9 and Bax) markers in fibroblasts from patients with Alzh

1 March 2012 in Brain Research
Verified
Journal Article
Closed access
SCSónia C. Correia
Sónia C. Correia
Renato Xavier Coelho dos SantosRenato Xavier Coelho dos Santos
Renato Xavier Coelho dos Santos
Cristina CarvalhoCristina Carvalho
Cristina Carvalho
SCSusana Cardoso
Susana Cardoso
ECEmanuel Candeias
Emanuel Candeias
Paula I. MoreiraPaula I. Moreira
Paula I. Moreira

1 June 2007 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
Paula I. MoreiraPaula I. Moreira
Paula I. Moreira
MSMaria S. Santos
Maria S. Santos
RSRaquel Seiça
Raquel Seiça
COCatarina R. Oliveira
Catarina R. Oliveira

17 April 2009 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
Paula I. MoreiraPaula I. Moreira
Paula I. Moreira
Ana DuarteAna Duarte
Ana Duarte
MSMaria S. Santos
Maria S. Santos
Ana Cristina Cristina RegoAna Cristina Cristina Rego
Ana Cristina Cristina Rego
COCatarina R. Oliveira
Catarina R. Oliveira
The processes underlying the pathogenesis of Alzheimer's disease involve several factors including impaired glucose/energy metabolism, mitochondrial dysfunction, oxidative stress and altered insulin-signaling pathways. This review is mainly devoted t